Vertex Pharmaceuticals Inc. buy EPG2026
Start price
27.01.13
/
50%
€34.73
Target price
19.04.13
€40.00
Performance (%)
85.13%
End price
19.04.13
€64.30
Summary
This prediction ended on 19.04.13 with a price of €64.30. The BUY prediction by EPG2026 for Vertex Pharmaceuticals Inc. saw massive gains of 85.13%. EPG2026 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 3.135% | 3.135% | -1.238% | 44.615% |
| iShares Core DAX® | 2.331% | 5.140% | 25.000% | 65.619% |
| iShares Nasdaq 100 | 2.077% | 2.956% | 8.935% | 111.545% |
| iShares Nikkei 225® | 2.759% | 7.214% | 22.171% | 56.683% |
| iShares S&P 500 | 1.613% | 2.893% | 6.249% | 68.722% |
Comments by EPG2026 for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Sehr gute Biotechaktie
Vertex Pharma hat gute Produkte in der Pipeline
(Vom Mitglied beendet)

